MedCap
  • Home
  • About MedCap
    • About MedCap
    • Mission and Objectives
    • Investment Strategy
    • MedCap as an Owner
    • Board of Directors
    • Management
  • Operations
    • Operations
    • MedTech Business Area
    • Specialty Pharma Business Area
    • Acquisition History
  • Investors
    • Investors
    • MedCap as an Investment
    • The Share
      • Share Data
      • Changes in Share Capital
      • Shareholder Structure
      • Insider Trading
      • Analysts and Market Makers
      • Dividend Policy
    • Financial Information
      • Interim Reports
      • Prospectus
      • Annual Reports
      • Presentations
      • Financial Targets
      • Investor Policy
      • IR Calendar
      • IR Contacts
      • Definitions
      • Accounting Policies
      • Key Figures
    • Corporate Governance
      • Corporate Governance Report
      • Articles of Association
      • General Meeting
      • Nomination Committee
      • Board Duties
      • Committees
      • Board Remuneration
      • Internal Controls
      • Management Duties
      • Remuneration
      • Auditors
    • Calendar
  • Sustainability
  • GDPR
  • Media
    • Media
    • Press Releases
      • Regulatory Press Releases
      • None-Regulatory Press Releases
    • Request Information
  • Contact
  • Search

Prospectus

On 15 February 2016, Nasdaq Stockholm’s Listing Committee admitted MedCap AB’s shares to trading on the Nasdaq Stockholm main market. The shares were consequently delisted from Nasdaq First North Premier. The final day for trading in MedCap’s shares on Nasdaq First North Premier was 24 February 2016, and the first day for trading on the main market was 25 February 2016. The share is from 4th of January 2021 traded in the Mid Cap segment. For further information, please read the prospectus prepared in connection with the change of listing: Listing Prospectus (in Swedish).

  • Investors
  • MedCap as an Investment
  • The Share
    • Share Data
    • Changes in Share Capital
    • Shareholder Structure
    • Insider Trading
    • Analysts and Market Makers
    • Dividend Policy
  • Financial Information
    • Interim Reports
    • Prospectus
    • Annual Reports
    • Presentations
    • Financial Targets
    • Investor Policy
    • IR Calendar
    • IR Contacts
    • Definitions
    • Accounting Policies
    • Key Figures
  • Corporate Governance
    • Corporate Governance Report
    • Articles of Association
    • General Meeting
    • Nomination Committee
    • Board Duties
    • Committees
    • Board Remuneration
    • Internal Controls
    • Management Duties
    • Remuneration
    • Auditors
  • Calendar
  • About MedCap
  • Mission and Objectives
  • Investment Strategy
  • MedCap as an Owner
  • Board of Directors
  • Management
  • Operations
  • MedTech Business Area
  • Specialty Pharma Business Area
  • Acquisition History
  • Investors
  • Investors
  • The Share
  • Financial Information
  • Corporate Governance
  • Calendar
  • Media
  • Press Releases
  • Request Information
  • Image Archive
  • Contact
MedCap AB | Sundbybergsvägen 1 | 171 73 Solna | +46 8 34 71 10 | info@medcap.se
Scroll to top